Why BioDelivery Sciences International Stock Was Up 28.5% Monday

The biotech company received a favorable court ruling regarding its lead therapy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.